Tozaro

Molecular Imprinted polymers as alternatives to antibodies.

Tozaro designs and develops synthetic affinity reagents to enhance complex cell and gene therapy processes.

  • Investment status Current
  • Invested 2015
  • Category Health & Life Sciences